Ribolex

Click here to view the pdf brochure

Click here to view the manufacturer's license

RIBOLEX™ is simply the purest most refined composition which has been used by thousands of ophthalmologists world-wide for well over 10 years, assuring controllable, efficient and safe corneal cross linking (CXL) procedures.

Manufactured under the most stringent of GMP practices in Australia, Ribolex remains the highest grade compound of choice for the most discerning physicians, available in 5 formulations and compatible for use with all types corneal cross linking Devices.

Indications

Ribolex solutions are considered as topical use, non-pharmaceutical Vitamin B2 agents indicated for topical use in treatment of progressive keratoconus and cornea ectasia as extension of refractive surgery. Suitable for use in conjunction with all commercially available corneal collagen cross-linking devices.

Warning and Precautions

There have not been any side effects related specifically to Ribolex compound. However in corneal cross-linking procedure as whole adverse reactions are rare although may result in corneal opacity (haze), punctate keratitis, corneal striae, corneal epithelium defect, eye pain, some reduced visual acuity. For more information, the physician must refer to Prescribing Information and specific corresponding Corneal Cross-Link device operator’s manual.

Disclaimer

Publication of any information contained in this brochure is prohibited. Information contained in this brochure has been compiled with the utmost care using sources and resources classified as highly reliable. All statements and information made in this brochure or by Ribolex Pty. Ltd. are for information purposes only and completely obligation. All information should be examined and verified by an independent source, as it is the physicians’ responsibility to familiarize themselves with the latest recommended treatment techniques and parameters of the device used.